Lunit

Lunit builds a modular AI ecosystem that connects imaging, pathology, and biomarker insights across the entire cancer care pathway. It delivers clinically validated solutions designed to integrate into real-world workflows for detecting cancer earlier and guiding treatment decisions. The company positions its tools as engines of clinical insight that unify data types and drive scale in cancer care.

Lunit trains its AI on large, diverse datasets sourced through global clinical partnerships, aiming for reliable performance across populations.

The company highlights a global presence and collaboration with healthcare and biopharma leaders. It describes a setup where FDA-cleared and CE-marked products are used in thousands of sites across many countries, indicating clinically validated solutions across the cancer care continuum.

Lunit presents a future-ready strategy leveraging multimodal data integration to power detection, risk stratification, spatial analysis, and biomarker development, with a focus on scaling and real-world impact across screening, diagnosis, treatment planning, and drug development.

Use cases

• AI for radiology and oncology to elevate detection, diagnostics, treatment planning, and biomarker development with real-world proven tools.